A carregar...
Long-Term Survival in Metastatic Pancreatic Adenocarcinoma and Cholangiocarcinoma Can Be Achieved With “Metronomic Dosing” of Paclitaxel/Oxaliplatin/Leucovorin/5-Fluorouracil (POLF) and Possibly Other Chemotherapy Regimens
BACKGROUND: Patients with metastatic pancreatic adenocarcinoma (PC) and cholangiocarcinoma (CC) have a poor prognosis, with median survivals of 3 to 6 months and poor quality of life. A weekly, “metronomic dosing” of chemotherapy allows for increased dose density and dose intensity, but with good to...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Society of Gastrointestinal Oncology
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056301/ |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|